Diagnosis of Clinically Significant Prostate Cancer Diagnosis Without Histological Proof in the Prostate-specific Membrane Antigen Era: The Jury Is Still Out
Main Authors: | Mike Wenzel, Benedikt Hoeh, Philipp Mandel, Felix KH Chun |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-11-01
|
Series: | European Urology Open Science |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666168322019115 |
Similar Items
-
Clinically Significant Prostate Cancer Diagnosis Without Histological Proof: A Possibility in the Prostate-specific Membrane Antigen Era?
by: Joris G. Heetman, et al.
Published: (2022-10-01) -
Prostate Cancer Diagnosis Without Histological Proof: Is Treating Images Reasonable?
by: Olivier Rouvière, et al.
Published: (2022-12-01) -
Immunohistochemistry for Prostate Biopsy—Impact on Histological Prostate Cancer Diagnoses and Clinical Decision Making
by: Philipp Mandel, et al.
Published: (2021-06-01) -
Vascular closure devices: the jury is still out
by: Juan M. Ruiz-Nodar, et al.
Published: (2024-02-01) -
The era of prostate-specific membrane antigen for the diagnosis and treatment of prostate cancer: A novel horizon
by: Byeongdo Song, et al.
Published: (2023-05-01)